ABNX.PA
Price:
$3.505
Market Cap:
$121.68M
ABIONYX Pharma SA, a biotech company, discovers and develops therapies for the treatment of renal and ophthalmological diseases. The company is developing CER-001, a negatively-charged lipoprotein particle which contains human recombinant apoA-I, the natural high density lipoprotein (HDL) protein, and sphingomyelin and dipalmitoylphosphatidylglycerol natural phospholipids designed to mimicks the structural and functional biological properties of pre-beta HDL for the treatment of post-acute coronary syndrome patients and familial primary hypoalphalipoproteinemia patients; CER-002, a peroxisome proliferator-activated receptor delta specific agonist for the treatment of cardiovascular and metab...[Read more]
Industry
Biotechnology
IPO Date
2015-03-30
Stock Exchange
PAR
Ticker
ABNX.PA
According to ABIONYX Pharma S.A.’s latest financial reports and current stock price. The company's current Enterprise Value is 122.42M. This represents a change of 208.21% compared to the average of 39.72M of the last 4 quarters.
The mean historical Enterprise Value of ABIONYX Pharma S.A. over the last ten years is 53.57M. The current 122.42M Enterprise Value has changed 22.75% with respect to the historical average. Over the past ten years (40 quarters), ABNX.PA's Enterprise Value was at its highest in in the December 2015 quarter at 189.42M. The Enterprise Value was at its lowest in in the June 2019 quarter at -1875668.00.
Average
53.57M
Median
38.38M
Minimum
-206137.00
Maximum
174.70M
Discovering the peaks and valleys of ABIONYX Pharma S.A. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 340.62%
Maximum Annual Enterprise Value = 174.70M
Minimum Annual Increase = -6469.75%
Minimum Annual Enterprise Value = -206137.00
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 39.62M | 6.65% |
| 2023 | 37.15M | -22.81% |
| 2022 | 48.13M | -16.82% |
| 2021 | 57.85M | 340.62% |
| 2020 | 13.13M | -6469.75% |
| 2019 | -206137.00 | -106.54% |
| 2018 | 3.15M | -87.46% |
| 2017 | 25.14M | -81.64% |
| 2016 | 136.98M | -21.59% |
| 2015 | 174.70M | -19.30% |
The current Enterprise Value of ABIONYX Pharma S.A. (ABNX.PA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
41.63M
5-year avg
39.18M
10-year avg
53.57M
ABIONYX Pharma S.A.’s Enterprise Value is less than OSE Immunotherapeutics S.A. (125.94M), less than Innate Pharma S.A. (124.13M), less than Adocia S.A. (133.26M), less than Genfit S.A. (285.61M), greater than Sensorion S.A. (57.66M), less than Transgene S.A. (139.51M), greater than Crossject S.A. (119.64M), less than Cellectis S.A. (388.38M), greater than MaaT Pharma S.A. (63.60M), less than Median Technologies S.A. (151.25M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 125.94M | $112.67M | |
| 124.13M | $150.80M | |
| 133.26M | $128.97M | |
| 285.61M | $254.21M | |
| 57.66M | $102.76M | |
| 139.51M | $125.72M | |
| 119.64M | $108.30M | |
| 388.38M | $300.87M | |
| 63.60M | $64.23M | |
| 151.25M | $116.57M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ABIONYX Pharma S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like ABIONYX Pharma S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is ABIONYX Pharma S.A.'s Enterprise Value?
What is the highest Enterprise Value for ABIONYX Pharma S.A. (ABNX.PA)?
What is the 3-year average Enterprise Value for ABIONYX Pharma S.A. (ABNX.PA)?
What is the 5-year average Enterprise Value for ABIONYX Pharma S.A. (ABNX.PA)?
How does the current Enterprise Value for ABIONYX Pharma S.A. (ABNX.PA) compare to its historical average?